FERTIN PHARMA A/S — Credit Rating and Financial Key Figures

FERTIN PHARMA A/S (CVR number: 25834844) is a company from VEJLE. The company reported a net sales of 1012.6 mDKK in 2023, demonstrating a growth of 13.4 % compared to the previous year. The operating profit percentage was poor at -7.5 % (EBIT: -75.9 mDKK), while net earnings were -136.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was -4.6 %, which can be considered poor and Return on Equity (ROE) was -25.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 18.3 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. FERTIN PHARMA A/S's liquidity measured by quick ratio was 1.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.